Skip to main content
News Hagelueken 08.2022 1
PD Dr. Gregor Hagelueken (left) and Dr. Martin Peter (right)
© Johann Saba / UKB

News categories: Publication

Cross-validation of distance measurements in proteins

Large scale analysis of PELDOR/DEER and smFRET as complementary tools in structural biology

In order to investigate intermolecular distances, conformational changes or structural heterogeneity of biological molecules, two different methods are widely used: Pulsed electron-electron double resonance spectroscopy (PELDOR/DEER) and single-molecule Förster resonance energy transfer spectroscopy (smFRET). Scientists of the excellence cluster ImmunoSensation2 at the University of Bonn and of the Ludwig-Maximilians-Universität (LMU) Munich have now compared the accuracy of the two methods. The study has now been published in the journal Nature Communications.

The researchers from PD Dr. Gregor Hagelueken's group at the Institute of Structural Biology of the University Hospital Bonn (UKB) used four different proteins as model structures to be analyzed: Three different substrate binding proteins (SBPs), and an actin-binging virulence factor, all four exhibiting large conformational changes upon ligand binding. PELDOR spectroscopy was used to determine inter-probe distances at the nanometre scale and detect conformational changes of the macromolecules in their (frozen) solution state. Identical experiments were carried out at the research group of Prof. Dr. Thorben Cordes at LMU Munich, using smFRET spectroscopy.

"Although both methods are used very frequently, no one has yet systematically investigated whether the results are really comparable," says Hagelueken. Although it turned out that the results were comparable in most cases, the researchers encountered inconsistencies in two cases. Bonn post-doctoral researcher Martin Peter says, "We then thoroughly investigated what caused the differences and found what we were looking for. In one case, it turned out that the dye molecules stuck to the protein and thus falsified the measurement." In the second case, the addition of a type of antifreeze, which was necessary because of the low measurement temperature of below -220 degrees Celsius, led to unexpected deviations. "We were able to show that despite the high accuracy of the methods, re-measuring with another nano ruler is always a good idea," Hagelueken says.


Publication

Martin F. Peter, Christian Gebhardt, Rebecca Mächtel, Gabriel G. Moya Muñoz Janin Glaenzer, Alessandra Narducci, Gavin H. Thomas, Thorben Cordes, Gregor Hagelueken: Cross-validation of distance measurements in proteins by PELDOR/DEER and single-molecule FRET; Nature Communications; https://doi.org/10.1038/s41467-022-31945-6



Contact

PD Dr. Gregor Hagelueken

Institute for Structural Biology

University Hospital Bonn

Phone: +49 228 287-51200

Email: hagelueken(at)uni-bonn.de

Related news

Kathrin Leppek Publication PM

News categories: Publication

Starting points for the control of protein synthesis

Bonn researchers develop a versatile toolbox for the characterization of IRESes in cells.
View entry
Pandyra Publication Graphical Abstract

News categories: Publication

Genetic mutation affects survival after viral infection

Scientists discovered that haploinsufficiency in the Pax5 gene affects antiviral responses. The study was led by Prof. Dr. Aleksandra Pandyra from the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn in collaboration with Prof. Dr. Arndt Borkhardt, Clinic Director at the Pediatric Oncology at the University Hospital Düsseldorf. The findings were published in the latest edition of EMBO Molecular Medicine.
View entry
AG Kürthen Multiple Sclerosis Bonn

News categories: Publication

Potential target for MS therapy discovered

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, which are a type of white blood cell, play a role in the development of MS and are thus a target for therapies. Researchers at the University Hospital Bonn (UKB), the University of Bonn and the FAU Erlangen-Nuremberg identified the membrane protein MLC1 as a potential target antigen in MS. The results of the work have now been published in the renowned journal “Neurology Neuroimmunology & Neuroinflammation”.
View entry

Back to the news overview